ArticleBMC medical genomics2019

Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients.

Alexander V Lavrov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.